Type-2 Diabetes Case Study Original PDF 2023

In 2018, I received a diagnosis of type-2 diabetes, which catalyzed my commitment to managing my health through systematic documentation of key health metrics. I initiated a regular regimen of tracking my blood glucose levels, which were recorded at values exceeding the normal range of 74-100 mg/dL, accompanied by an HbA1C level of 11.5%. At that juncture, my weight was 185 lbs, with a height of 5 feet 11.5 inches. While already utilizing Dr. Amy Lee’s BIO-X4 probiotic as part of a program guided by a Nutritionist and Weight Management Specialist, I observed a notable ancillary benefit: my HbA1C level decreased dramatically to as low as 3.5%.

I maintained a diligent practice of monitoring my finger-stick blood glucose levels before each meal—breakfast, lunch, and dinner. On February 15th, I incorporated Dr. Marlene Merritt’s Blood Glucose Formula (BGF) into my regimen to evaluate its effects on my blood glucose measurements. Significantly, I noted a differentiation in my pre-lunch and pre-dinner readings from my pre-breakfast (nocturnal) glucose levels. This change proved to be statistically significant, with pre-dinner levels showing a more rapid divergence, thereby facilitating the characterization of both nocturnal and diurnal phases of diabetes.

Additionally, I employed LibreLink technology to corroborate and enhance my finger-stick data. In advancing this research, it is imperative to validate this singular case study of type-2 diabetes with a diverse cohort of ten patients—comprising five females and five males. Furthermore, extending this investigation to encompass non-diabetic individuals and individuals with severe diabetes will provide a more comprehensive understanding of diabetes and elucidate the critical role of glucose, a universal energy molecule present in every cell, in the maintenance of optimal health.